Rentokil Initial plc (RKLIF)
| Market Cap | 16.15B +42.0% |
| Revenue (ttm) | 6.91B +4.4% |
| Net Income | 470.00M +19.9% |
| EPS | 0.19 +19.5% |
| Shares Out | n/a |
| PE Ratio | 34.35 |
| Forward PE | 22.05 |
| Dividend | 0.12 (1.95%) |
| Ex-Dividend Date | Apr 9, 2026 |
| Volume | n/a |
| Average Volume | 6,030 |
| Open | 6.37 |
| Previous Close | 6.37 |
| Day's Range | 6.37 - 6.37 |
| 52-Week Range | 4.05 - 6.52 |
| Beta | 0.42 |
| RSI | 65.25 |
| Earnings Date | Jul 30, 2026 |
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey, and Pacific. The company offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management. It provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene u... [Read more]
Financial Performance
In 2025, Rentokil Initial's revenue was $6.91 billion, an increase of 4.40% compared to the previous year's $6.62 billion. Earnings were $470.00 million, an increase of 19.90%.
Financial StatementsNews
Terminix Debuts New Podcast to Help Businesses Mitigate Operational Risk
The pest collective: “From root cause to real solutions” launches this Spring The pest collective: “From root cause to real solutions” launches this Spring
Rentokil Initial Earnings Call Transcript: Q1 2026
Q1 revenue grew 3.4% organically to $1.7B, led by North America and solid international gains. Business Services saw exceptional growth, though not expected to persist, while pricing remains the main driver amid stable retention and minimal impact from fuel or supply chain risks.
Rentokil Initial PLC (RTO) Shares Surge 3.5% -- What GF Score of 88 Tells Investors
Rentokil Initial PLC (RTO) Shares Surge 3.5% -- What GF Score of 88 Tells Investors
Rentokil Initial PLC Announces Annual Financial Report
Annual Report and Annual General Meeting CRAWLEY, UK / ACCESS Newswire / March 25, 2026 / In compliance with UK Listing Rule 6.4.1, the Company announces that the following documents, in unedited full...
Rentokil Initial price target raised to 575 GBp from 550 GBp at Citi
Citi analyst Marc Van’T Sant raised the firm’s price target on Rentokil Initial (RTO) to 575 GBp from 550 GBp and keeps a Buy rating on the shares. Published first
Rentokil Initial upgraded to Buy from Neutral at UBS
UBS analyst Nicole Manion upgraded Rentokil Initial (RTO) to Buy from Neutral with a price target of 540 GBp, up from 430 GBp. The firm says that for the first
Rentokil Initial upgraded to Neutral from Sell at Rothschild & Co Redburn
Rothschild & Co Redburn upgraded Rentokil Initial (RTO) to Neutral from Sell with a 470 GBp price target
Rentokil Initial price target raised to 550 GBp from 520 GBp at Morgan Stanley
Morgan Stanley raised the firm’s price target on Rentokil Initial (RTO) to 550 GBp from 520 GBp and keeps an Overweight rating on the shares.
Rentokil Initial price target raised to $35 from $30 at Oppenheimer
Oppenheimer raised the firm’s price target on Rentokil Initial (RTO) to $35 from $30 and keeps an Outperform rating on the shares. The firm notes Rentokil’s Q4 revenues of $1.7B
Rentokil Initial price target raised to 550 GBp from 500 GBp at Citi
Citi analyst Marc Van’T Sant raised the firm’s price target on Rentokil Initial (RTO) to 550 GBp from 500 GBp and keeps a Buy rating on the shares. Published first
Rentokil Initial price target raised to 550 GBp from 520 GBp at Morgan Stanley
Morgan Stanley analyst Annelies Vermeulen raised the firm’s price target on Rentokil Initial (RTO) to 550 GBp from 520 GBp and keeps an Overweight rating on the shares. The firm,
Rentokil Initial price target raised to 550 GBp from 520 GBp at Morgan Stanley
Morgan Stanley raised the firm’s price target on Rentokil Initial (RTO) to 550 GBp from 520 GBp and keeps an Overweight rating on the shares.
Rentokil Initial price target raised to 540 GBp from 500 GBp at RBC Capital
RBC Capital raised the firm’s price target on Rentokil Initial (RTO) to 540 GBp from 500 GBp and keeps an Outperform rating on the shares.
Rentokil Initial rises 11.1%
Rentokil Initial (RTO) is up 11.1%, or $3.18 to $31.93.
Rentokil Initial jumps after reporting better revenue amid leadership change
Rentokil reported better than expected revenue for 2025 on improved performance in the second half of the year amid leadership changes. The company said revenue in 2025 climbed 2.6% organically
Rentokil Initial rises 12.0%
Rentokil Initial (RTO) is up 12.0%, or $3.45 to $32.20.
Rentokil Initial Earnings Call Transcript: H2 2025
Revenue grew 3.8% to $6.9B with 2.6% organic growth, and adjusted operating profit rose 5.4%. North America and international segments both improved, with strong cash flow and margin expansion. Strategic focus remains on branch expansion, brand investment, and AI-driven efficiency.
Rentokil Initial Reports Higher Revenue Amid Leadership Transition
The pest-control, hygiene and workwear-services provider's revenue climbed 2.6% organically in 2025.
Rentokil Initial downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Rentokil Initial (RTO) to Hold from Buy with a price target of 465 GBp, down from 505 GBp. The firm says its analysis shows Rentokil’s pest control
The Silent Destroyers: Terminix Reveals the Top Termite-Infested U.S. States
MEMPHIS, Tenn.--(BUSINESS WIRE)--As termite swarms begin emerging nationwide, Terminix®, a Rentokil Terminix company, today released its first-ever Top Termite-Infested U.S. States Report. Backed by 2...
Rentokil Initial downgraded to Sell from Neutral at Rothschild & Co Redburn
Rothschild & Co Redburn downgraded Rentokil Initial (RTO) to Sell from Neutral with a 420 GBp price target
Rentokil Initial upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Annelies Vermeulen upgraded Rentokil Initial (RTO) to Overweight from Equal Weight with a price target of 520 GBp, up from 450 GBp. The firm adjusted rating in
Rentokil Initial upgraded to Buy from Neutral at BofA
BofA analyst Simona Sarli upgraded Rentokil Initial (RTO) to Buy from Neutral with a price target of $34, up from $28. The firm also added Rentokil Initial to its “Europe
Rentokil Initial reinstated with an Overweight at JPMorgan
JPMorgan analyst Jane Sparrow reinstated coverage of Rentokil Initial (RTO) with an Overweight rating and 477 GBp price target The firm believes the company’s recent improving organic growth trends wi...
Rentokil Initial price target raised to 500 GBp from 440 GBp at RBC Capital
RBC Capital raised the firm’s price target on Rentokil Initial (RTO) to 500 GBp from 440 GBp and keeps an Outperform rating on the shares.